Title: Polymorphisms in the CRP and C1Q genes and schizophrenia in Armenian population: A pilot study
1Polymorphisms in the CRP and C1Q genes and
schizophrenia in Armenian population A pilot
study
- Zakharyan R1,2, Khoyetsyan A1, Chavushyan A1,
- Arakelyan A1, Boyajyan A1, Stahelova A2, Mrazek
F2, - Petrek M2,3
- 1Laboratory of Macromolecular Complexes,
Institute of Molecular Biology, Yerevan, NAS
Armenia - 2Laboratory of Immunogenomics and Proteomics,
Dept. of Immunology, Medical Faculty, Palacky
University, Olomouc - 3 Div. of Clinical Biochemistry and
Immunogenetics, Faculty Hospital, Olomouc
2Schizophrenia
- Schizophrenia is a complex mental disease with
genetic component characterized by behavioral,
cognitive and social abnormalities - According to data provided by the World Health
Organization (WHO, 2008) this disease affects
about 7 per thousand of the adult population,
mostly in the age group 15-35 years (first
episodes) - Disease heritability is about 80, siblings
recurrence risk is 10
3CRP ? C1Q in schizophrenia
- CRP is an acute and chronic phase inflammation
marker. - C1Q is the first and key component of classical
activation pathway of complement and consists of
3 subunits C1QA, C1QB, C1QC. - The CRP (Hakobyan et al, 2005 Dickerson et al.
2007) and C1Q (Boyajyan et al, 2008) are
upregulated in schizophrenia, and likely
contribute to disease progression - Hypothesis
- The functional variants of the CRP and C1Q genes
might be involved in pathogenesis of
schizophrenia.
4- Objective
- To investigate possible association of selected
variants in CRP and C1Q genes with susceptibility
to schizophrenia. - Selected SNP variants
- CRP
- rs1417938 (T/A) intron
- rs1800947 (C/G) intron
- rs1205 (C/T) UTR-3
- C1QB
- rs291982 (G/T) intron
- rs631090 (T/C) intron
5Subjects and methods
- Study population
- patients with paranoid schizophrenia n103
- healthy subjects n105
- all subjects unrelated Armenians
-
- Methods
- DNA extraction Standard phenol-chloroform method
using 3-5ml venous blood from subjects of both
groups - Genotyping Polymerase chain reaction with
sequence-specific primers (PCR-SSP) - Statistical analysis Pearsons Chi-square test
was performed for analysis of genotyping data.
6Results CRP
Proportion of mutant allele frequencies
rs1417938
rs1205
rs1800947
7Results CRP
8Results CRP
- The distribution of genotypes for all 3 CRP SNPs
corresponded to the Hardy-Weinberg equilibrium - No association between the selected three SNPs in
the CRP gene and schizophrenia has been found
(Pgt0.05).
9Results C1QB
Proportion of mutant allele
rs291982
Pn0.01 OR0,46 0.5346ltCIlt0.9084
Control
Schizophrenia
10Results C1QB
- The distribution of genotypes for both C1QB SNPs
corresponded to the Hardy-Weinberg equilibrium - The carriers of the C1QB rs291982T allele were
significantly less frequent in patients with
schizophrenia compared to control subjects
(Pnominal0.01, Pcorr0.05) - No association between the C1QB rs631090 SNP and
schizophrenia has been found.
11Conclusions
- Polymorphism rs291982 of the C1QB gene is
associated with schizophrenia in this pilot
study. - C1QB gene variants or a locus located nearby may
therefore be involved in susceptibility to
schizophrenia. - No association between the C1QB rs631090 SNP and
schizophrenia has been found. - No association between the selected variants of
the CRP gene and schizophrenia was observed.
12Discussion
- To our knowledge, this is the first study
investigating a relationship of C1Q gene with
schizophrenia. - According to the recommendation for the genetic
association studies our results should be
replicated in independent cohorts. - The exact role of C1Q molecules and their gene
variants in schizophrenia remains to be
clarified.
13- Future plans
- To enlarge study group for gaining more
statistical power and for subanalysis according
to the particular disease phenotypes - To evaluate several other CRP polymorphisms to
achieve more coverage of the gene - To investigate additional two SNPs within C1Q
genes (rs913243 and rs172378) using PCR
techniques - To perform haplotype mapping for C1Q genes
14Presenting author Roksana Zakharyan
- PhD Student Junior researcher
- Institute of Molecular Biology, Yerevan, Armenia
Acknowledgements
Study is supported by International Visegrad
Fund Prof. Anna Boyajyan, DrSc Yeravan,
Armenia Prof. MUDr. Martin Petrek, CSc MUDr.
Frantisek Mrazek, PhD. Olomouc, Czech Republic
15Thank you